SCHEMBL16763492

SCHEMBL16763492

COc1ccc(-c2cc3[nH]c(C(=O)O)cc3s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.48
IKBKB O14920 2/20 0.47
ALPL P05186 1/20 0.47
CA9 Q16790 1/20 0.47
HDAC6 Q9UBN7 1/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
TP53 P04637 2/20 0.46
RAB9A P51151 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
KDM4E B2RXH2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31634882 0.85 RAB9A (0.59) ALDH1A1HPGDMAPTSMN1; SMN2NPC1
SCHEMBL69502 0.83 DAO (0.51) PTPN1IKBKBALDH1A1HPGDMAPT
SCHEMBL4263996 0.73 PDGFRB (0.61) HDAC6ALDH1A1HPGDNPC1RAB9A
SCHEMBL20494459 0.73 FLT3 (0.55) ALPLCA9HPGDMAPTNPC1
SCHEMBL30071213 0.73 FLT3 (0.55) ALPLCA9HPGDMAPTNPC1
SCHEMBL913901 0.73 FLT3 (0.50) ALPLCA9ALDH1A1HPGDSMN1; SMN2
SCHEMBL4086143 0.73 RAB9A (0.49) ALDH1A1HPGDMAPTSMN1; SMN2NPC1
SCHEMBL69116 0.72 HPGD (0.58) ALDH1A1HPGDMAPTSMN1; SMN2NPC1
SCHEMBL16763557 0.71 APP (0.50) PTPN1IKBKBHDAC6ALDH1A1HPGD
SCHEMBL4191153 0.70 NR4A2 (0.49) ALPLCA9ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12337069-B1 Detoxifying light emitting device and use thereof GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2025-06-24 US claimed
US-12337069-B1 Detoxifying light emitting device and use thereof GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2025-06-24 US disclosed
US-9611281-B2 BODIPY derivatives and methods of synthesis and use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2017-04-04 US disclosed
US-20150158888-A1 BODIPY Derivatives and Methods of Synthesis and Use Thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158888-A1 BODIPY Derivatives and Methods of Synthesis and Use Thereof FDPS, FDFT1, BCR PTPN1 4710/4885IKBKB 610/4885ALPL 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.